NDC 69097-391

deferasirox

Deferasirox

deferasirox is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Cipla Usa Inc.. The primary component is Deferasirox.

Product ID69097-391_292b99a9-0f98-41e4-b4d0-f13213a97f15
NDC69097-391
Product TypeHuman Prescription Drug
Proprietary Namedeferasirox
Generic NameDeferasirox
Dosage FormTablet, Coated
Route of AdministrationORAL
Marketing Start Date2020-02-13
Marketing CategoryANDA / ANDA
Application NumberANDA211852
Labeler NameCipla USA Inc.
Substance NameDEFERASIROX
Active Ingredient Strength90 mg/1
Pharm ClassesIron Chelating Activity [MoA],Iron Chelator [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Cytochrome P450 1A2 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 69097-391-02

30 TABLET, COATED in 1 BOTTLE (69097-391-02)
Marketing Start Date2020-02-13
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 69097-391-20 [69097039120]

deferasirox TABLET, COATED
Marketing CategoryANDA
Application NumberANDA211852
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-02-13

NDC 69097-391-02 [69097039102]

deferasirox TABLET, COATED
Marketing CategoryANDA
Application NumberANDA211852
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2020-02-13

NDC 69097-391-19 [69097039119]

deferasirox TABLET, COATED
Marketing CategoryANDA
Application NumberANDA211852
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-02-13

Drug Details

Active Ingredients

IngredientStrength
DEFERASIROX90 mg/1

Pharmacological Class

  • Iron Chelating Activity [MoA]
  • Iron Chelator [EPC]
  • Cytochrome P450 3A4 Inducers [MoA]
  • Cytochrome P450 2C8 Inhibitors [MoA]
  • Cytochrome P450 1A2 Inhibitors [MoA]

NDC Crossover Matching brand name "deferasirox" or generic name "Deferasirox"

NDCBrand NameGeneric Name
45963-454DeferasiroxDeferasirox
45963-456DeferasiroxDeferasirox
45963-455DeferasiroxDeferasirox
46708-326DeferasiroxDeferasirox
46708-410DEFERASIROXDEFERASIROX
46708-325DeferasiroxDeferasirox
46708-324DeferasiroxDeferasirox
46708-412DEFERASIROXDEFERASIROX
62332-326DeferasiroxDeferasirox
62332-324DeferasiroxDeferasirox
62332-325DeferasiroxDeferasirox
62332-410DEFERASIROXDEFERASIROX
62332-412DEFERASIROXDEFERASIROX
67877-551DeferasiroxDeferasirox
67877-550DeferasiroxDeferasirox
67877-549DeferasiroxDeferasirox
69539-023DeferasiroxDeferasirox
69539-073DeferasiroxDeferasirox
69539-022DeferasiroxDeferasirox
69539-075DeferasiroxDeferasirox
69539-021DeferasiroxDeferasirox
70710-1277deferasiroxdeferasirox
70710-1275deferasiroxdeferasirox
43598-851DeferasiroxDeferasirox
43598-855DeferasiroxDeferasirox
43598-856DeferasiroxDeferasirox
43598-853DeferasiroxDeferasirox
43598-854DeferasiroxDeferasirox
62756-569deferasiroxdeferasirox
62756-570deferasiroxdeferasirox
62756-568deferasiroxdeferasirox
69452-159DeferasiroxDeferasirox
69452-161DeferasiroxDeferasirox
69452-160DeferasiroxDeferasirox
70771-1471deferasiroxdeferasirox
70771-1473deferasiroxdeferasirox
0093-3515DeferasiroxDeferasirox
0093-3517DeferasiroxDeferasirox
0591-3853DeferasiroxDeferasirox
16714-995deferasiroxdeferasirox
16714-993deferasiroxdeferasirox
0078-0468Exjadedeferasirox
0078-0469Exjadedeferasirox
0078-0470Exjadedeferasirox
0078-0654Jadenudeferasirox
0078-0655Jadenudeferasirox
0078-0656Jadenudeferasirox
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.